Benadryl

Anemia, Sickle Cell

Columbia UniversityPhase 1/2Active

CCC

55/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 44/ 100
Competitive Position: 89/ 100

Competitive context

8 Active assets in the Anemia, Sickle Cell cohort.

Asset / Sponsor	Phase	Rating
MAGNESIUM METALLICUM Medical College of Wisconsin	Phase 3	BB
FENTANYL University College Dublin	Phase 4	BB
PEGYLATED CARBOXYHEMOGLOBIN BOVINE Prolong Pharmaceuticals	Phase 2	BB
ARG Claudia R. Morris	Phase 3	BB
Ddavp Montefiore Medical Center	Phase 4	BB

View all 30 →

Same molecule, other indications

Benadryl is also rated in:

Relapsing Chronic Myelogenous LeukemiaDormant

BBB

Indicative ·

74 / 100

Recurrent Adult Hodgkin LymphomaDormant

BBB

Indicative ·

74 / 100

Recurrent Adult Acute Myeloid LeukemiaDormant

BBB

Indicative ·

72 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.